Chuangxing Guo

USPTO Granted Patents = 8 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 83(Granted Patents)

Location History:

Encinitas, CA (US) (2003)
San Diego, CA (US) (2010 - 2022)

Company Filing History:

Agouron Pharmaceuticals, Inc.

patents

1 out of 3

Zeno Royalties & Milestones, LLC

patents

4. 1 out of 5

Suzhou Kintor Pharmaceuticals, Inc.

patents

5. 1 out of 27

Recurium IP Holdings, LLC

patents

where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11242346 - Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof (2022-02-08),

2. 10975035 - Bicyclic compounds (2021-04-13),

3. 10308609 - Bicyclic compounds (2019-06-04),

4. 8530652 - Pyrrolopyrazoles, potent kinase inhibitors (2013-09-10),

5. 8067591 - Pyrrolopyrazole, potent kinase inhibitors (2011-11-29),

6. 7884117 - Carbonylamino pyrrolopyrazoles, potent kinase inhibitors (2011-02-08),

7. 7772246 - Pyrazole compounds as RAF inhibitors (2010-08-10),

8. 6544987 - Compounds, compositions, and methods for stimulating neuronal growth and elongation (2003-04-08),

Title: Innovations and Contributions of Chuangxing Guo

Introduction

Chuangxing Guo is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic applications targeting various diseases. With a total of eight patents to his name, Guo's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Guo has developed inhibitors for the mechanistic target of rapamycin (mTOR) signaling pathway. These selective mTOR inhibitors are designed to treat diseases and disorders arising from abnormal cell growth, which include cancer, immune disorders, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders, and neurological disorders. Additionally, he has disclosed bicyclic compounds that serve as analgesics, detailing methods for synthesizing these compounds and their potential therapeutic uses.

Career Highlights

Chuangxing Guo has worked with notable companies in the pharmaceutical industry, including Pfizer Corporation and Agouron Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug therapies.

Collaborations

Guo has collaborated with esteemed colleagues such as Liming Dong and Anle Yang. These partnerships have fostered innovation and have been instrumental in advancing his research initiatives.

Conclusion

Chuangxing Guo's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of treatments for various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.